Omer Sahin

Omer Sahin

Auto-generated profile, based on publicly available information

Omer Sahin

Department of Cardiology, Kayseri Education and Research Hospital, Kayseri, Turkey

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2014 in Medical Principles and Practice
Verified
Journal Article
Open access
PDF file
OSOmer Sahin
Omer Sahin
MAMahmut Akpek
Mahmut Akpek
BSBahadir Sarli
Bahadir Sarli
ABAhmet Oguz Baktir
Ahmet Oguz Baktir
GSGoktug Savas
Goktug Savas
HAHuseyin Arinc
Huseyin Arinc
Objectives: The aim of this study was to evaluate the association of the levels of red blood cell distribution width (RDW) with the severity of atherosclerosis and to determine whether or not the RDW level on admission is an independent predictor of all-cause mortality in patients with non-ST elevation myocardial infarction (NSTEMI). Materials and Methods: A total of 335 consecutive patients with NSTEMI were enrolled in this study. The patients were divided into high (n = 105) and low (n = 230) SYNTAX groups. The high SYNTAX group was defined as patients with a value in the third tertile (SYNTAX score, SXscore ≥12), while the low SYNTAX group was defined as those with a value in the lower 2 tertiles (SXscore 14.25% and the low RDW group (n = 183) as those with RDW ≤14.25%. All-cause mortality was followed up to 38 months. Results: The mean follow-up period was 18 ± 11 months. The RDW levels of patients were significantly higher in the high SYNTAX group than in the low SYNTAX group (15.2 ± 1.8 vs. 14.2 ± 1.2, p < 0.001). Pearson's coefficients were used to determine the degree of association between RDW levels and SXscore and also between RDW levels and high-sensitivity C-reactive protein. There was a significant correlation between RDW levels and SXscore (r = 0.460, p < 0.001). Also, there was a significant correlation between RDW levels and high-sensitivity C-reactive protein (r = 0.180, p = 0.001). All-cause mortality rate was not significantly different between the high and low RDW groups (log-rank, p = 0.621). Conclusion: RDW levels were independently associated with high SXscore but were not associated with long-term mortality in NSTEMI patients.

1 January 2017 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
OSOmer Sahin
Omer Sahin
The extent of severity and complexity of coronary artery disease (CAD) in patients presenting with ST-segment elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI) and possible correlations between serum 25-hydroxyvitamin D (25(OH)D) have not yet been adequately studied. We evaluated the relationship between 25(OH)D levels and the burden of CAD as assessed by the SYNTAX score (SXscore) in patients with acute coronary syndrome (ACS) including STEMI and NSTEMI. After exclusion, a total of 113 patients who were admitted to our hospital due to ACS and who were referred for undergoing coronary angiography were prospectively included. Their mean age was 63.3±18.5 years, and 80.5% of them were men. In total, 44.2% of the patients had NSTEMI and the remaining had STEMI. Blood samples were drawn at admission to evaluate serum 25(OH)D levels. CAD severity was assessed using the SXscore. Patients were classified as having low (SXscore ≤22) or high (SXscore >22) SXscores. Pearson’s and Spearman’s correlation coefficients were used to examine the relationship between serum 25(OH)D levels and the SXscore. 25(OH)D levels were significantly lower in the group with a high SXscore than in the group with a low SXscore (21.0±8.0 vs. 16.7±6.8, p=0.005). Correlation analysis showed a significant correlation between 25(OH)D levels and the SXscore. Multiple linear regression (MLR) analysis was used to determine the significance of the relationship between the SXscore and 25(OH)D, parathyroid hormone, and C-reactive protein levels and eGFR. MLR analysis revealed that only 25(OH)D levels (coefficient beta, -0.217, p=0.029) was significantly associated with the severity of CAD. The present study showed that serum 25(OH)D levels were significantly lower in patients with STEMI/NSTEMI and that low serum 25(OH)D levels were significantly correlated with CAD severity and extent. (Anatol J Cardiol 2017; 17: 293-7)

1 February 2011
Verified
Journal Article
Closed access
ODOrhan Dogdu
Orhan Dogdu
MYMikail Yarlioglues
Mikail Yarlioglues
MKMehmet Gungor Kaya
Mehmet Gungor Kaya
IAIdris Ardic
Idris Ardic
YKYusuf Kilinc
Yusuf Kilinc
AOAbdurrahman Oguzhan
Abdurrahman Oguzhan

30 November 2023 in Acta Cardiologica
Verified
Journal Article
Closed access
SKSerhat Karadavut
Serhat Karadavut
MCMurat Cetin
Murat Cetin
OSOmer Sahin
Omer Sahin
BackgroundWhile there has been a wealth of reports concerning the acute effects of the coronavirus disease 2019 (COVID-19), further information is needed to see how things unfold in the long run. This research aimed to ascertain whether the COVID-19 pandemic has increased the probability of thromboembolic events in atrial fibrillation (AF) patients.MethodsIn this retrospective study, we scanned 952 AF patients and classified 643 eligible ones per their history of catching COVID-19. Two hundred thirty-nine of 643 patients had a history of COVID-19 (Group 1), and 404 did not (Group 2). We then compared two years of thromboembolic events between the groups.ResultsComposite thromboembolic outcomes were seen in 76 (11.8%) patients. Of those, 32 (13.4%) were in Group 1, and 44 (10.8%) were in Group 2 (p = .03). 10 of 32 patients (31%) in Group 1 and 11 of 44 (25%) in Group 2 died because of thromboembolic events (p = .02). Histories of diabetes mellitus, chronic obstructive pulmonary disease, and COVID-19 independently predicted thromboembolic events in AF patients.ConclusionsHaving caught COVID-19 is likely to be associated with increased long-term thromboembolic outcomes in AF patients. Albeit the study design does not permit us to infer causality, our results question the necessity of more intensive anticoagulant therapy and closer follow-up in AF patients with past COVID-19.

15 June 2020 in Bitlis Eren Üniversitesi Fen Bilimleri Dergisi
Verified
Journal Article
Closed access
PDF file
SHSabit HOROZ
Sabit HOROZ
AEArzu Eki̇nCi̇
Arzu Eki̇nCi̇
ÖŞÖmer Şahi̇n
Ömer Şahi̇n
Bu çalışmada, bir hidrojen jeneratörü tasarlamak için Co-La-B katalizörü kullanılarak katalizör miktarı, NaOH konsantrasyonu, NaBH4 konsantrasyonu ve çözelti sıcaklığı gibi parametrelerin hidrojen üretim hızı üzerindeki etkisi incelenmiştir. Hidrojen üretim reaksiyonu için aktivasyon enerjisi 40.3 kJ mol-1 olarak hesaplanmıştır. Co-La-B katalizörünü kullanıldığı hidrojen üretim sistemini kullanarak, polimer elektrolit membran yakıt hücresi (PEMFC) yığını çalıştırılmıştır. Yerinde üretilen hidrojen PEM yakıt pilinde kullanılarak, yakıt pili verimi hesaplanmıştır. Üretilen hidrojenin zamanla akım ve gerilim üzerindeki değişimleri incelenmiştir. Yerinde üretilen hidrojenin tek hücreli 1W PEM yakıt pilinde kullanılması ile akım ve gerilim değerlerinden, 0,65 W’lık bir güç değeri hesaplanmıştır. PEM yakıt pili uygulamasında güce ve ideal voltaja göre ortalama verim değerleri sırasıyla %62 ve %79 olarak bulunmuştur. Elde edilen sonuçlardan, Co-La-B katalizörünün PEM yakıt pili uygulamaları için ideal bir katalizör olduğu söylenebilir.

2 February 2015 in Echocardiography
Verified
Journal Article
Closed access
PDF file
MAMahmut Akpek
Mahmut Akpek
OSOmer Sahin
Omer Sahin
BSBahadir Sarli
Bahadir Sarli
HAHuseyin Arinc
Huseyin Arinc
ABAhmet O. Baktir
Ahmet O. Baktir
MKMehmet G. Kaya
Mehmet G. Kaya